Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Northwest Biotherapeutics
Northwest Biotherapeutics
Risk of Pivotal Study Failure Rises for NewLink and Northwest Bio
TheStreet.com
Fri, 03/7/14 - 12:28 pm
NewLink Genetics
Northwest Biotherapeutics
DCVax-L
HyperAcute Pancreas
Panel recommends Northwest Bio brain-cancer trial continue
Yahoo/Reuters
Fri, 03/7/14 - 09:21 am
Northwest Biotherapeutics
glioblastoma multiforme
clinical trials
DCVax-L
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
TheStreet.com
Mon, 03/3/14 - 11:55 am
glioblastoma multiforme
DCVax
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics
Tiny Northwest Biotherapeutics aims to dominate brain cancer
Yahoo/Reuters
Wed, 02/26/14 - 08:41 am
Northwest Biotherapeutics
DCVax-L
brain cancer
ImmunoCellular: Is Approval Enough?
Seeking Alpha
Mon, 02/24/14 - 11:12 am
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
glioblastoma multiforme
Focus On Cancer Immunotherapy Results
Seeking Alpha
Sat, 01/25/14 - 10:58 am
cancer immunotherapy
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
The Race To Develop A Brain Cancer Treatment Takes An Interesting Turn
Forbes
Fri, 12/27/13 - 01:01 pm
brain cancer
glioblastoma multiforme
ImmunoCellular Therapeutics
Northwest Biotherapeutics
CytRx
Celldex Therapeutics
aldoxorubicin
DCVax
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
Immunocellular Shares Are Set For A Rebound
Seeking Alpha
Fri, 12/20/13 - 08:37 am
ImmunoCellular Therapeutics
ICT-107
Northwest Biotherapeutics
Why Northwest Bio's DCVax Brain Tumor Vaccine Will Blow Up Just Like ImmunoCellular's ICT-107
TheStreet.com
Tue, 12/17/13 - 08:50 am
Northwest Biotherapeutics
DCVax
ICT-107
glioblastoma multiforme
ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
Seeking Alpha
Mon, 12/16/13 - 07:32 am
ICT-107
ImmunoCellular
Northwest Biotherapeutics
An In-Depth Look At 3 Companies Fighting GBM Brain Cancer
Seeking Alpha
Mon, 12/9/13 - 03:11 pm
glioblastoma multiforme
Agenus
ImmunoCellular Therapeutics
Northwest Biotherapeutics
If Northwest Biotherapeutics Wins, It Wins Big
Seeking Alpha
Mon, 12/2/13 - 08:44 am
Northwest Biotherapeutics
DCVax
brain cancer
solid tumors
Northwest Biotherapeutics Poses Onyx Like Potential
Seeking Alpha
Mon, 11/18/13 - 09:56 am
Northwest Biotherapeutics
Agenus
Celldex
ONYX Pharmaceuticals
ImmunoCellular Therapeutics
Why Northwest Biotherapeutics Rose 40% And Where From Here
Seeking Alpha
Tue, 11/12/13 - 08:28 am
Northwest Biotherapeutics
DCVax
brain cancer
Recent Developments With Northwest Bio Hint At Big Move In 3 To 4 Months
Seeking Alpha
Thu, 10/3/13 - 05:30 pm
Northwest Biotherapeutics
DCVax
prostate cancer
brain cancer
A Small Biotech With Breakthrough Potential In Cancer Treatment
Seeking Alpha
Mon, 07/22/13 - 11:35 am
DCVax
Northwest Biotherapeutics
prostate cancer
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
Minyanville
Tue, 06/18/13 - 11:53 am
immunotherapy
Celldex
OncoSec
ImmunoCellular Therapeutics
Northwest Biotherapeutics
With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curse
Seeking Alpha
Wed, 05/1/13 - 11:03 am
Northwest Biotherapeutics
Pages
« first
‹ previous
1
2
3
next ›
last »